Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06291874 As Oral Monotherapy To Treat Adults With Type 2 Diabetes Mellitus
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 172 participants.
Also called NCT02175121
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 172 participants
- Sponsor
- Registry
-
NCT02175121
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT02175121. Randomized; double masking; primary purpose treatment. Start 2014-08 (registry gives no type); primary completion 2015-03 (actual). Results posted on 2016-06-15.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06291874 As Oral Monotherapy To Treat Adults With Type 2 Diabetes Mellitus
- Condition
- Diabetes Mellitus, Type II
- Intervention (Drug)
- Placebo
- Intervention (Drug)
- PF-06291874
- Intervention (Drug)
- PF-06291874
- Intervention (Drug)
- PF-06291874
- Intervention (Drug)
- PF-06291874
- Lead sponsor
- Pfizer
Record details
- Record id
cardio:ct-nct02175121- Content hash
4ef294ef0037da739b04b6fcbcb929beba664fd70efb032187da01b28a1ebd56